Literature DB >> 12919882

Recombinant osteogenic protein-1 upregulates extracellular matrix metabolism by rabbit annulus fibrosus and nucleus pulposus cells cultured in alginate beads.

K Masuda1, K Takegami, H An, F Kumano, K Chiba, G B J Andersson, T Schmid, E Thonar.   

Abstract

This study was performed to determine if recombinant human osteogenic protein-1 (rhOP-1) is effective in promoting matrix synthesis and matrix formation by rabbit nucleus pulposus (NP) and annulus fibrosus (AF) cells cultured in alginate beads. The effects of culturing the cells in the presence of various concentrations of rhOP-1 were assessed by measuring changes in cell proliferation, proteoglycan (PG) and collagen synthesis and mRNA expression, and in the matrix contents of PG and collagen, as indicators of matrix accumulation. At high concentrations, rhOP-1 had a moderate mitogenic effect on both NP and AF cells. It also stimulated the synthesis of PG and collagen in a dose-dependent manner: this was associated with a corresponding increase in the expression of mRNA for aggrecan core protein and collagen type II. The stimulatory effect of rhOP-1 on PG synthesis was more pronounced than that on collagen synthesis. Continuous treatment with rhOP-1 led to an increase in the total DNA, PG and collagen contents in both NP and AF cultures. The results presented here provide evidence of the ability of rhOP-1 to stimulate the metabolism of both rabbit AF and NP cells cultured in alginate beads.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12919882     DOI: 10.1016/S0736-0266(03)00037-8

Source DB:  PubMed          Journal:  J Orthop Res        ISSN: 0736-0266            Impact factor:   3.494


  31 in total

Review 1.  Emerging technologies for molecular therapy for intervertebral disk degeneration.

Authors:  Won C Bae; Koichi Masuda
Journal:  Orthop Clin North Am       Date:  2011-10       Impact factor: 2.472

2.  Next Generation Mesenchymal Stem Cell (MSC)-Based Cartilage Repair Using Scaffold-Free Tissue Engineered Constructs Generated with Synovial Mesenchymal Stem Cells.

Authors:  Kazunori Shimomura; Wataru Ando; Yu Moriguchi; Norihiko Sugita; Yukihiko Yasui; Kota Koizumi; Hiromichi Fujie; David A Hart; Hideki Yoshikawa; Norimasa Nakamura
Journal:  Cartilage       Date:  2015-03-24       Impact factor: 4.634

3.  The effect of capacitively coupled (CC) electrical stimulation on human disc nucleus pulposus cells and the relationship between CC and BMP-7.

Authors:  Zili Wang; William C Hutton; S Tim Yoon
Journal:  Eur Spine J       Date:  2016-02-18       Impact factor: 3.134

Review 4.  Molecular therapy of the intervertebral disc.

Authors:  S Tim Yoon; Nilpesh M Patel
Journal:  Eur Spine J       Date:  2006-07-12       Impact factor: 3.134

5.  Stemming the Degeneration: IVD Stem Cells and Stem Cell Regenerative Therapy for Degenerative Disc Disease.

Authors:  V Sivakamasundari; Thomas Lufkin
Journal:  Adv Stem Cells       Date:  2013

6.  PDGF, bFGF and IGF-I stimulate the proliferation of intervertebral disc cells in vitro via the activation of the ERK and Akt signaling pathways.

Authors:  Harris Pratsinis; Dimitris Kletsas
Journal:  Eur Spine J       Date:  2007-09-01       Impact factor: 3.134

Review 7.  New challenges for intervertebral disc treatment using regenerative medicine.

Authors:  Koichi Masuda; Jeffrey C Lotz
Journal:  Tissue Eng Part B Rev       Date:  2010-02       Impact factor: 6.389

Review 8.  Mechanical design criteria for intervertebral disc tissue engineering.

Authors:  Nandan L Nerurkar; Dawn M Elliott; Robert L Mauck
Journal:  J Biomech       Date:  2010-01-18       Impact factor: 2.712

9.  Intervertebral disc degeneration: biological and biomechanical factors.

Authors:  Howard S An; Koichi Masuda; Nozomu Inoue
Journal:  J Orthop Sci       Date:  2006-10       Impact factor: 1.601

Review 10.  Repair, regenerative and supportive therapies of the annulus fibrosus: achievements and challenges.

Authors:  Johannes Leendert Bron; Marco N Helder; Hans-Jorg Meisel; Barend J Van Royen; Theodoor H Smit
Journal:  Eur Spine J       Date:  2008-12-23       Impact factor: 3.134

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.